558 related articles for article (PubMed ID: 3605132)
1. Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis.
Shusterman NH; Wasserstein AG; Morrison G; Audet P; Fallon MD; Kaplan F
Am J Med; 1987 Jun; 82(6):1148-56. PubMed ID: 3605132
[TBL] [Abstract][Full Text] [Related]
2. [Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry].
Kucharska E; Stompór T; Sułowicz W; Drozdz M; Kaczmarczyk I; Szymczakiewicz-Multanowska A; Chruściel B; Kraśnicka M
Przegl Lek; 2000; 57(6):334-9. PubMed ID: 11107868
[TBL] [Abstract][Full Text] [Related]
3. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
Weinreich T; Passlick-Deetjen J; Ritz E
Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
[TBL] [Abstract][Full Text] [Related]
4. Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis.
Gokal R; Ramos JM; Ellis HA; Parkinson I; Sweetman V; Dewar J; Ward MK; Kerr DN
Kidney Int; 1983 Jan; 23(1):15-21. PubMed ID: 6834691
[No Abstract] [Full Text] [Related]
5. Renal osteodystrophy in CAPD patients.
Zucchelli P; Catizone L; Casanova S; Fusaroli M; Fabbri L; Ferrari G
Miner Electrolyte Metab; 1984; 10(5):326-32. PubMed ID: 6493161
[TBL] [Abstract][Full Text] [Related]
6. Effects of in-center daily hemodialysis upon mineral metabolism and bone disease in end-stage renal disease patients.
Lugon JR; André MB; Duarte ME; Rembold SM; Cruz E
Sao Paulo Med J; 2001 May; 119(3):105-9. PubMed ID: 11391452
[TBL] [Abstract][Full Text] [Related]
7. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
8. Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol.
Arora N; Sandroni S; Moles K
Adv Perit Dial; 1992; 8():62-4. PubMed ID: 1361854
[TBL] [Abstract][Full Text] [Related]
9. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
[TBL] [Abstract][Full Text] [Related]
10. Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide.
Hercz G; Andress DL; Nebeker HG; Shinaberger JH; Sherrard DJ; Coburn JW
Am J Kidney Dis; 1988 Jan; 11(1):70-5. PubMed ID: 3337101
[TBL] [Abstract][Full Text] [Related]
11. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
Hewitt IK; Stefanidis C; Reilly BJ; Kooh SW; Balfe JW
J Pediatr; 1983 Nov; 103(5):729-34. PubMed ID: 6631599
[TBL] [Abstract][Full Text] [Related]
12. Renal osteodystrophy and aluminum bone disease in CAPD patients.
Gokal R
Clin Nephrol; 1988; 30 Suppl 1():S64-7. PubMed ID: 3052962
[TBL] [Abstract][Full Text] [Related]
13. [Osteodystrophy in children with chronic renal insufficiency in dialysis therapy].
Bartolozzi G; Pela I; Lavoratti GC; Bettucci E; Sirovich A; Pierattelli M; Materassi M
Pediatr Med Chir; 1982; 4(1-2):65-9. PubMed ID: 6287442
[TBL] [Abstract][Full Text] [Related]
14. Controlled study of renal osteodystrophy in patients undergoing dialysis.
Pitts TO
Am J Med; 1987 Dec; 83(6):1171-3. PubMed ID: 3332573
[No Abstract] [Full Text] [Related]
15. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
[TBL] [Abstract][Full Text] [Related]
16. The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis.
Meyrier A; Marsac J; Richet G
Kidney Int; 1973 Aug; 4(2):146-53. PubMed ID: 4744972
[No Abstract] [Full Text] [Related]
17. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
18. Renal bone disease in pediatric patients receiving treatment with maintenance peritoneal dialysis.
Salusky IB; Goodman WG
Child Nephrol Urol; 1991; 11(3):165-8. PubMed ID: 1777895
[TBL] [Abstract][Full Text] [Related]
19. The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease.
Freemont AJ; Hoyland JA; Denton J;
Clin Nephrol; 2005 Dec; 64(6):428-37. PubMed ID: 16370155
[TBL] [Abstract][Full Text] [Related]
20. Renal osteodystrophy in children on CAPD: a prospective trial of 1-alpha-hydroxycholecalciferol therapy.
Watson AR; Kooh SW; Tam CS; Reilly BJ; Balfe JW; Vieth R
Child Nephrol Urol; 1988-1989; 9(4):220-7. PubMed ID: 3255485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
